Journal of the Korean Ophthalmological Society 1995;36(11):1833-1841.
Published online November 1, 1995.
Chemomyectomy Effect of Doxorubicin and Verapamil on Orbicularis Oculi in Rabbit.
Jong Gil Kweon, Dong Hun Kwak, Ji Myeong Yoo, Jun Kyeong Song
Department of Ophthalmology, College of Medicine, Gyeong-Sang National University, Chinju, Korea.
가토의 안윤근에 Doxorubicin 과 Verapamil 병용치료에 의한 화학적 근절제술의 효과
권종길(Jong Gil Kweon),곽동훈(Dong Hun Kwak),유지명(Ji Myung Yoo),송준경(Jun Kyung Song)
Abstract
Doxorubicin has characteristic chemomyectomy effect of the eyelid without disturbing other eyelid structures, but the major side effect of doxorubicin is the potential for eyelid skin injury as a result of the drug's toxicity in both animal and clinical studies. Verapamil may be used to reduce the dose of doxorubicin and the number of injections that would amplify the toxic effects of doxorubicin. This study was performed to determine whether there is an increase in the toxic effect of the doxorubicin as a result of verapamil pretreatment of the muscle. After 0.5mg, 1.0mg, and 2.0mg doxorubicin was injected in lower eyelids of each group, and equal dose of doxorubicin was injected fo11owing 1.0mg of verapamil injection in lower eyelid of each group, muscle cell loss were measured by light microscopy and side effect was observed. In verapamil and doxorubicin injection group, there was significant differences in the amount of preseptal muscle and even in the pretarsal muscle than the doxorubicin injection group in all doxorubicin doses. Verapamil, injected with a range of doses of doxorubicin, caused suhstantia11y increased muscle loss in the eyelid, compared with injection of doxorubicin alone. Skin ulceration, entropion or ectropion were not visible. Clinically, verapamil cotreatment might be useful to decrease the dose of doxorubicin injected and/or the total number of injections.
Key Words: Doxorubicin;Muscle fiber;Verapamil


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next